Was DNA testing just a fad? The genetic testing company 23andMe laid off 100 employees Thursday, which is about 14% of its ...

The founder of 23andMe Research Institute wants to reach 100 million users, an ambitious goal after the seller of DNA testing kits emerged from bankruptcy as a nonprofit. 23andMe has the DNA of about ...

Bankrupt genetic-testing firm 23andMe agreed to sell its data bank, which once contained DNA samples from about 15 million people, to the drug developer Regeneron Pharmaceuticals for $256 million. The ...

DNA testing and genealogy companies are stepping up user account security by mandating the use of two-factor authentication, following the theft of millions of user records from DNA genetic testing ...

Drugmaker Regeneron Pharmaceuticals will buy genetic testing firm 23andMe for $256 million through a bankruptcy auction, the companies said Monday. Regeneron said it will comply with 23andMe’s privacy ...

Customers of the genetic testing company 23andMe have until July 14 to file a claim as part of a restructuring in its bankruptcy case. In filing a claim, eligible customers can seek compensation for ...

A nonprofit controlled by Anne Wojcicki, former chief executive of 23andMe, has won the bidding process to buy the bankrupt genetic testing company. If approved by the court, the sale would put ...

Following a data breach and bankruptcy, genetic testing service 23andMe will soon be in different hands. On Monday, biotechnology company Regeneron announced that it won the top bid in a bankruptcy ...

Valerie is a seasoned writer and editor who has spent her career creating content in the parenting and women's wellness spaces. Before joining Forbes Health, Valerie was the trending news editor at ...

Bankrupt genetic-testing firm 23andMe has agreed to sell its data bank, which once contained DNA samples from about 15 million people, to the drug developer Regeneron Pharmaceuticals for $256 million.